首页 > 抗体蛋白 > 抗体
APC/Cyanine7 anti-mouse TCR β chain Antibody
产品名称:
APC/Cyanine7 anti-mouse TCR β chain Antibody
产品类别:
抗体
产品编号:
109219
产品应用:
109219
[价格]
规格 价格 库存
25µg ¥ 1128 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Affinity purified TCR from mouse DO-11.10 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

H57-597 is a hamster mAb directed to an epitope of the C region of TCR ? chain12. The H57-597 antibody does not cross-react with ?/d TCR-bearing T cells. Immobilized or soluble H57-597 antibody can activate a/? TCR-bearing T cells. Additional reported applications (for the relevant formats) for this antibody include: immunoprecipitation2, in vitro stimulation2,3, in vivo depletion4-6, and immunohistochemical staining of acetone-fixed frozen sections7,8,9. The Ultra-LEAF? purified antibody (Endotoxin <0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 109253-109258).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Gascoigne NJ. 1990. J. Biol. Chem. 265:9296.
  2. Kruisbeek A, et al. 1991. In Current Protocols in Immunology. pp. 3.12.1. (Costim IP)
  3. Davenport C, et al. 1995. J. Immunol. 155:3742. (Costim)
  4. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  5. Kummer U, et al. 2001. Immunol. Lett. 75:153. (Deplete)
  6. van der Heyde HC, et al. 1995. J. Immunol. 154:3985. (Deplete)
  7. Tomita K, et al. 1999. Genes Dev. 13:1203. (IHC)
  8. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
  9. Ponomarev ED, et al. 2007. J. Immunol. 178:39. (IHC)
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Tsukumo S, et al. 2006. J.Immunol. 177:8365. (FC) PubMed
  12. Grégoire C, et al. 1991. Proc. Natl. Acad. Sci USA 88:8077.
Product Citations
  1. Dillon T, et al. 2013. Int Immunol. 25:259. PubMed
  2. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  3. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  4. Cibrián D, et al. 2020. J Allergy Clin Immunol. 145:199. PubMed
  5. Xu K, et al. 2021. Immunity. 54(5):976-987.e7. PubMed
  6. Acker A, et al. 2014. PLoS One. 9:110015. PubMed
  7. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  8. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  9. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  10. Alcaraz-Serna A, et al. 2021. Sci Adv. 7:. PubMed
  11. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  12. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  13. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  14. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  15. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  16. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  17. Higa T, et al. 2022. Nat Commun. 13:1500. PubMed
  18. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  19. Broeck T, et al. 2013. J Immunol. 190:1982. PubMed
  20. Hirata Y, et al. 2015. PLoS One. 10: 0141785. PubMed
  21. Devos M, et al. 2020. J Exp Med. 217:00:00. PubMed
  22. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  23. Hojo MA, et al. 2019. Nat Commun. 2.224305556. PubMed
  24. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  25. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  26. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  27. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  28. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  29. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  30. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  31. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  32. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  33. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  34. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  35. de Reuver R, et al. 2021. Cell Reports. 36(6):109500. PubMed
  36. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  37. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  38. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  39. Jin C, et al. 2019. Cell. 176:998. PubMed
  40. Huang L, et al. 2020. Front Immunol. 10:3103. PubMed
  41. Giampazolias E, et al. 2021. Cell. . PubMed
  42. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  43. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  44. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  45. Yabas M, et al. 2011. PLoS One. 6:e26440. PubMed
  46. Seki N, et al. 2022. iScience. 25:104838. PubMed
  47. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  48. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  49. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  50. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  51. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  52. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  53. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  54. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  55. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  56. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  57. Wang X, et al. 2022. Elife. 11:. PubMed
  58. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  59. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  60. Sch?fer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  61. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  62. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  63. Stienne C, et al. 2022. Cell Rep. 38:110553. PubMed
  64. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_893626 (BioLegend Cat. No. 109219) AB_893624 (BioLegend Cat. No. 109220)

Antigen Details

Structure
Ig superfamily, CD3/TCR complex with CD3 and TCR α subunit
Distribution

Majority of T cells and thymocytes (correlated to differentiation)

Function
Antigen recognition, T cell activation
Ligand/Receptor
Peptide bound-MHC class I and II
Antigen References

1. Davis MM, et al. 1998. Ann. Rev. Immunol. 16:523.
2. Huppa JB, et al. 2003. Nat. Immunol. 4:749.
3. Kubo R, et al. 1989. J. Immunol. 142:2736.

Gene ID
21577 View all products for this Gene ID
UniProt
View information about TCR beta chain on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线